METHOD OF COMBINED TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY Russian patent published in 2013 - IPC A61F9/07 A61K31/14 A61P27/06 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be used for treatment of glaucomatous optic neuropathy. Method includes carrying out sinus trabeculectomy and introduction of medication citicoline (ceraxon). Citicoline is introduced in dependence on structural and functional eye disorders after sinus trabeculectomy in differentiated manner, combining intravenous introduction of citicoline with its intake. To patients with I-II stage of glaucoma citiciline is introduced intravenously fy drop infusion in dose 500 mg daily during 5 days with further transition to intake in dose 200 mg 3 times per day during 10 days. Patients with III stage of glaucoma citicoline is introduced intravenously by drop infusion in dose 1000 mg daily during 5 days with further transition to intake in dose 200 mg 3 times per day during 15 days.

EFFECT: method ensures efficient treatment of disease, making it possible to avoid "excessive" drug load and reduce probability of development of side effects, especially in elderly patients.

2 ex